B. Kaschten et al., PREOPERATIVE EVALUATION OF 54 GLIOMAS BY PET WITH FLUORINE-18-FLUORODEOXYGLUCOSE AND OR CARBON-II-METHIONINE/, The Journal of nuclear medicine, 39(5), 1998, pp. 778-785
This study evaluates the usefulness of PET far the preoperative evalua
tion of brain gliomas and methods of quantification of PET results. Me
thods: Fifty-four patients with brain gliomas were studied by PET with
F-18-fluorodeoxyglucose (FDG) (n = 45) and/or C-11-methianine (MET) (
n = 41) before any treatment. Results of visual analysis, calculation
of glucose consumption and five tumor-to-normal brain ratios far both
tracers were correlated with two histologic grading systems and with f
ollow-up. Results: Visual analysis (for FDG) and tumor-to-mean cortica
l uptake (T/MCU) ratio proved to be the best tools far the evaluation
of PET results. Methionine was proven to be better than FDG at delinea
ting low-grade gliomas. Tumor-to-mean cortical uptake ratios for FDG a
nd MET were clearly correlated (r = 0.78), leading to the equation T/M
CUFDG = 0.4.T/MCUMET. We showed a good correlation between FDG PET and
histologic grading. MET uptake could not differentiate between low-gr
ade and anaplastic astrocytomas but was significantly increased in gli
oblastomas. Low-grade oligodendrogliomas exhibited high uptake of FDG
and MET, probably depending more on oligodendroglial cellular differen
tiation than on proliferative potential. Uptake was decreased in anapl
astic oligodendrogliomas, probably due to dedifferentiation. Care must
be taken with peculiar histologic subgroups, i.e., juvenile pilocytic
astrocytomas and oligodendrogliomas, because of a discrepancy between
high PET metabolism and low proliferative potential (good prognosis).
Both tracers proved useful for the prediction of survival prognosis.
Methionine proved slightly superior to FDG for predicting the histolog
ic grade and prognosis of gliomas, despite the impossibility of differ
entiation between Grades II and III astrocytomas with MET. This superi
ority of MET could be explained by patient sampling (low number of Gra
de III gliomas submitted to examination with both tracers). The combin
ation of both tracers improved the overall results compared to each tr
acer alone. Conclusion: Both tracers are useful for the prediction of
the histologic grade and prognosis. The apparent superiority of MET ov
er FDG could be due to the small number of Grade III gliomas studied w
ith both tracers.